Fulgent Genetics Gross Margin 2015-2025 | FLGT
Current and historical gross margin for Fulgent Genetics (FLGT) over the last 10 years. The current gross profit margin for Fulgent Genetics as of September 30, 2025 is %.
| Fulgent Genetics Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $0.32B | $0.13B | 41.27% |
| 2025-06-30 | $0.30B | $0.12B | 39.93% |
| 2025-03-31 | $0.29B | $0.11B | 38.70% |
| 2024-12-31 | $0.28B | $0.11B | 37.81% |
| 2024-09-30 | $0.28B | $0.10B | 35.97% |
| 2024-06-30 | $0.29B | $0.11B | 38.83% |
| 2024-03-31 | $0.29B | $0.11B | 37.50% |
| 2023-12-31 | $0.29B | $0.11B | 36.21% |
| 2023-09-30 | $0.29B | $0.09B | 32.40% |
| 2023-06-30 | $0.31B | $0.10B | 32.14% |
| 2023-03-31 | $0.37B | $0.14B | 39.18% |
| 2022-12-31 | $0.62B | $0.37B | 59.29% |
| 2022-09-30 | $0.80B | $0.54B | 67.75% |
| 2022-06-30 | $0.93B | $0.68B | 73.73% |
| 2022-03-31 | $0.95B | $0.74B | 77.04% |
| 2021-12-31 | $0.99B | $0.78B | 78.25% |
| 2021-09-30 | $1.04B | $0.83B | 80.12% |
| 2021-06-30 | $0.91B | $0.72B | 79.23% |
| 2021-03-31 | $0.77B | $0.61B | 79.30% |
| 2020-12-31 | $0.42B | $0.33B | 78.67% |
| 2020-09-30 | $0.14B | $0.09B | 69.63% |
| 2020-06-30 | $0.04B | $0.03B | 58.14% |
| 2020-03-31 | $0.03B | $0.02B | 58.82% |
| 2019-12-31 | $0.03B | $0.02B | 58.06% |
| 2019-09-30 | $0.03B | $0.02B | 55.17% |
| 2019-06-30 | $0.03B | $0.01B | 52.00% |
| 2019-03-31 | $0.02B | $0.01B | 50.00% |
| 2018-12-31 | $0.02B | $0.01B | 50.00% |
| 2018-09-30 | $0.02B | $0.01B | 50.00% |
| 2018-06-30 | $0.02B | $0.01B | 47.37% |
| 2018-03-31 | $0.02B | $0.01B | 47.37% |
| 2017-12-31 | $0.02B | $0.01B | 52.63% |
| 2017-09-30 | $0.02B | $0.01B | 57.14% |
| 2017-06-30 | $0.02B | $0.01B | 61.90% |
| 2017-03-31 | $0.02B | $0.01B | 65.00% |
| 2016-12-31 | $0.02B | $0.01B | 66.67% |
| 2016-06-30 | $0.01B | $0.01B | 70.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.807B | $0.283B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $33.427B | 38.66 |
| Tempus AI (TEM) | United States | $10.416B | 0.00 |
| Doximity (DOCS) | United States | $7.021B | 28.91 |
| Hims & Hers Health (HIMS) | United States | $6.019B | 48.96 |
| IRhythm Holdings (IRTC) | United States | $5.017B | 0.00 |
| Privia Health (PRVA) | United States | $2.879B | 180.08 |
| Hinge Health (HNGE) | United States | $2.773B | 0.00 |
| 10x Genomics (TXG) | United States | $2.525B | 0.00 |
| Heartflow (HTFL) | United States | $2.451B | 0.00 |
| Omnicell (OMCL) | United States | $2.185B | 44.68 |
| Inspire Medical Systems (INSP) | United States | $2.134B | 35.31 |
| Azenta (AZTA) | United States | $1.726B | 70.81 |
| Enovis (ENOV) | United States | $1.268B | 6.66 |
| Clover Health Investments (CLOV) | United States | $1.137B | 0.00 |
| Schrodinger (SDGR) | United States | $1.038B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.965B | 0.00 |
| Phreesia (PHR) | United States | $0.796B | 0.00 |
| Talkspace (TALK) | United States | $0.683B | 137.33 |
| Standard BioTools (LAB) | United States | $0.542B | 0.00 |
| Claritev (CTEV) | United States | $0.459B | 0.00 |
| Evolent Health (EVH) | United States | $0.364B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.362B | 0.00 |
| Carlsmed (CARL) | United States | $0.331B | 0.00 |
| TruBridge (TBRG) | United States | $0.307B | 14.09 |
| Senseonics Holdings (SENS) | United States | $0.296B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.264B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.261B | 0.00 |
| CapsoVision (CV) | United States | $0.256B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.197B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.167B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.163B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.161B | 0.00 |
| CareCloud (CCLD) | United States | $0.114B | 6.28 |
| Outset Medical (OM) | United States | $0.090B | 0.00 |
| American Well (AMWL) | United States | $0.075B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| Pulmonx (LUNG) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| HeartBeam (BEAT) | United States | $0.050B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.045B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.018B | 0.00 |
| Movano (MOVE) | United States | $0.012B | 0.00 |
| Zhongchao (ZCMD) | China | $0.011B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.011B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |